Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Muscarinic acetylcholine receptors (mAChRs) are a family of G protein-coupled receptors that mediate the effects of the neurotransmitter acetylcholine. There are five known subtypes: M1, M2, M3, M4, and M5. A non-selective muscarinic receptor ligand interacts with all these subtypes. mAChRs play critical roles in mediating parasympathetic nervous system responses. Drugs targeting mAChRs include both selective and non-selective agents. Non-selective antagonists can cause broad anticholinergic effects due to their lack of subtype selectivity.
Agonists like acetylcholine or muscarine bind to the receptor, inducing a conformational change that activates intracellular G proteins and downstream signaling cascades. Antagonists like atropine block endogenous ligand binding, preventing receptor activation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscarinic Acetylcholine Receptor (non-selective) (None).